These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29530322)

  • 21. Current Use of Hearts From Hepatitis C Viremic Donors.
    Moayedi Y; Fan CPS; Gulamhusein AF; Manlhiot C; Ross HJ; Teuteberg JJ; Khush KK
    Circ Heart Fail; 2018 Dec; 11(12):e005276. PubMed ID: 30562093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
    Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
    Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.
    Kapila N; Al-Khalloufi K; Bejarano PA; Vanatta JM; Zervos XB
    Am J Transplant; 2020 Feb; 20(2):600-605. PubMed ID: 31448549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.
    Coilly A; Samuel D
    J Hepatol; 2016 Jan; 64(1):226-31. PubMed ID: 26375245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart Transplantation for Hepatitis C Virus Non-Viremic Recipients From Hepatitis C Virus Viremic Donors.
    Frager SZ; Dhand A; Gass A; Levine A; Spielvogel D; Nog R; Wolf DC; Bodin RI
    Cardiol Rev; 2019; 27(4):179-181. PubMed ID: 31180937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Couri T; Katz J; Stoeckle K; Nugooru A; Yeh H; Chung R; Paul S
    Am J Nephrol; 2019; 50(3):168-176. PubMed ID: 31390615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Outcomes of Multivisceral Transplant Using Hepatitis C-Positive Donors.
    McMaster WG; Rahaman ZM; Shipe ME; Quintana EN; Sandhaus EM; Smith SS; Crockett JE; Forbes RC; Schlendorf KH; Shah AS
    Ann Thorac Surg; 2021 Aug; 112(2):511-518. PubMed ID: 33121968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCV-infected solid organ donors, direct-acting antivirals and the current challenges.
    Fabrizi F; Cerutti R; Silva M
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):7-14. PubMed ID: 31786966
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I; Agudelo EZ; Sarkar M; Roberts JP; Terrault NA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.
    Sise ME; Chute DF; Gustafson JL; Wojciechowski D; Elias N; Chung RT; Williams WW
    Hemodial Int; 2018 Apr; 22 Suppl 1():S71-S80. PubMed ID: 29694722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue.
    Kling CE; Limaye AP; Landis CS; Sibulesky L
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28130837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C viraemic organs in solid organ transplantation.
    Weinfurtner K; Reddy KR
    J Hepatol; 2021 Mar; 74(3):716-733. PubMed ID: 33212088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access to hepatitis C direct-acting antiviral therapy in hepatitis C-positive donor to hepatitis C-negative recipient solid-organ transplantation in a real-world setting.
    Edmonds C; Carver A; DeClercq J; Choi L; Peter M; Schlendorf K; Perri R; Forbes RC; Concepcion BP
    Am J Surg; 2022 May; 223(5):975-982. PubMed ID: 34548142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.
    Fernández I; Muñoz-Gómez R; Pascasio JM; Baliellas C; Polanco N; Esforzado N; Arias A; Prieto M; Castells L; Cuervas-Mons V; Hernández O; Crespo J; Calleja JL; Forns X; Londoño MC
    J Hepatol; 2017 Apr; 66(4):718-723. PubMed ID: 28039098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents.
    Jung J; Kwon JH; Song GW; Tak EY; Kirchner VA; Lee SG
    J Gastrointest Surg; 2018 Aug; 22(8):1334-1342. PubMed ID: 29679347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.
    Chhatwal J; Samur S; Bethea ED; Ayer T; Kanwal F; Hur C; Roberts MS; Terrault N; Chung RT
    Hepatology; 2018 Jun; 67(6):2085-2095. PubMed ID: 29222916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C and liver transplantation.
    Martini S
    Minerva Gastroenterol Dietol; 2018 Jun; 64(2):158-169. PubMed ID: 28948755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A real-world, single-center experience of the utilization of hepatitis C-viremic kidneys for hepatitis C-negative recipients.
    Daloul R; Anthony M; Washburn K; Singh P; Pesavento T
    Clin Nephrol; 2021 Oct; 96(4):216-225. PubMed ID: 34169833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
    Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
    J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.